Products
Online Inquiry
ZLN005
Cat. No.:
OB0225WX-2688
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
ZLN005 is a high-potency transcriptional activator of PGC-1-alpha that exhibits significant tissue-specific activity.
Synonym:
49671-76-3; 2-(4-tert-butylphenyl)-1H-benzimidazole; 2-(4-(tert-butyl)phenyl)-1H-benzo[d]imidazole; 2-(4-tert-butylphenyl)-1H-benzo[d]imidazole; ZLN 005; ZLN-005; MFCD01560221; 2-(4-t-butylphenyl) benzimidazole; 2-(4-tert-Butylphenyl)benzimidazole; (1S,2R,3R,5S,6S,16E,18E,20R,21S)-11-Chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracycl o[19.3.1.110,14.03,5]hexacosa-10(26),11,13,16,18-pentaen-6-yl 2- methylpropanoate
CAS No.:
49671-76-3
Compound CID:
899323
Formula:
C17H18N2
Formula Weight:
250.34
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
ZLN005 is used in metabolic research as a potent transcriptional activator of PGC-1 alpha to investigate the enhancement of mitochondrial biogenesis and the improvement of glucose uptake in skeletal muscle cells.
Library Information
Target:
PGC-1α
Receptor:
PGC-1α
Pathways:
Metabolism
Plate Number:
L6700-08
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
37 mg/mL; 147.8 mM
Ethanol Max Solubility:
2 mg/mL
ALogP:
4.67
HBA_Count:
1
HBD_Count:
1
Rotatable Bond:
2
